AU2001266229A1 - Hcn polypeptides and polynucleotides and their use in therapy - Google Patents
Hcn polypeptides and polynucleotides and their use in therapyInfo
- Publication number
- AU2001266229A1 AU2001266229A1 AU2001266229A AU6622901A AU2001266229A1 AU 2001266229 A1 AU2001266229 A1 AU 2001266229A1 AU 2001266229 A AU2001266229 A AU 2001266229A AU 6622901 A AU6622901 A AU 6622901A AU 2001266229 A1 AU2001266229 A1 AU 2001266229A1
- Authority
- AU
- Australia
- Prior art keywords
- polynucleotides
- therapy
- hcn polypeptides
- hcn
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0016360A GB0016360D0 (en) | 2000-07-03 | 2000-07-03 | New use |
| GB0016360.0 | 2000-07-03 | ||
| GB0026946.4 | 2000-11-03 | ||
| GB0026946A GB0026946D0 (en) | 2000-11-03 | 2000-11-03 | Novel compounds |
| PCT/GB2001/002959 WO2002002630A2 (en) | 2000-07-03 | 2001-07-03 | Hcn polypeptides and polynucleotides and their use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001266229A1 true AU2001266229A1 (en) | 2002-01-14 |
Family
ID=26244586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001266229A Abandoned AU2001266229A1 (en) | 2000-07-03 | 2001-07-03 | Hcn polypeptides and polynucleotides and their use in therapy |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20040033943A1 (en) |
| EP (1) | EP1309624A2 (en) |
| AU (1) | AU2001266229A1 (en) |
| WO (1) | WO2002002630A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001272421A1 (en) | 2000-05-24 | 2001-12-03 | Akzo Nobel N.V. | Full length human hcn1 ih channel subunit and variants |
| CA2435292A1 (en) * | 2001-01-23 | 2002-08-15 | Merck & Co., Inc. | Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| MXPA03011330A (en) * | 2001-06-08 | 2004-12-06 | Johnson & Johnson | Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels. |
| EP1536020A1 (en) * | 2003-11-26 | 2005-06-01 | Bayerische Julius-Maximilians-Universität Würzburg | Means and methods for optical determination of cAMP in vitro and in vivo |
| US8859273B2 (en) * | 2003-12-24 | 2014-10-14 | Medtronic, Inc. | Methods of using HCN genes to treat cardiac arrhythmias |
| JP2009541333A (en) | 2006-06-23 | 2009-11-26 | クインテセンス バイオサイエンシーズ インコーポレーティッド | Modified ribonuclease |
| WO2008040027A2 (en) * | 2006-09-28 | 2008-04-03 | The Regents Of The University Of California | Directed differentiation and maturation of stem cell-derived cardiomyocytes |
| WO2009034108A1 (en) * | 2007-09-11 | 2009-03-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro beating heart model |
| WO2009036220A2 (en) | 2007-09-12 | 2009-03-19 | The Regents Of The University Of California | Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes |
| WO2013183985A1 (en) * | 2012-06-05 | 2013-12-12 | Erasmus University Medical Center Rotterdam | Method of treating cognitive impairment and compounds for use therein |
| EP3021946A2 (en) * | 2013-07-16 | 2016-05-25 | Karakossian, Movses | Hcn inhibitors affecting ganglion cell function and visual function |
| US10087436B2 (en) | 2014-02-06 | 2018-10-02 | The Regents Of The University Of California | Electrophysiologically mature cardiomyocytes and methods for making same |
| CA2948864C (en) | 2014-05-14 | 2023-10-17 | Karl E. Griswold | Deimmunized lysostaphin and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080773A (en) * | 1997-10-14 | 2000-06-27 | Akzo Nobel, N.V. | Benzylamine derivatives which are useful in treating psychiatric disorders |
| US6703485B2 (en) * | 1997-12-23 | 2004-03-09 | The Trustees Of Columbia University In The City Of New York | Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| DE19806581A1 (en) * | 1998-02-17 | 1999-10-21 | Forschungszentrum Juelich Gmbh | Ih ion channel sequences and their use |
-
2001
- 2001-07-03 US US10/311,795 patent/US20040033943A1/en not_active Abandoned
- 2001-07-03 WO PCT/GB2001/002959 patent/WO2002002630A2/en not_active Ceased
- 2001-07-03 AU AU2001266229A patent/AU2001266229A1/en not_active Abandoned
- 2001-07-03 EP EP01943697A patent/EP1309624A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002630A2 (en) | 2002-01-10 |
| EP1309624A2 (en) | 2003-05-14 |
| US20040033943A1 (en) | 2004-02-19 |
| WO2002002630A3 (en) | 2002-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL144954A0 (en) | Quinazolines and therapeutic use thereof | |
| AU2001266229A1 (en) | Hcn polypeptides and polynucleotides and their use in therapy | |
| WO2003099841A9 (en) | Peptides and the use thereof in darkening the skin | |
| AU2001265009A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
| IL153568A (en) | Novel polypeptides and polynucleotides | |
| AU2868601A (en) | Biaryl compounds, their preparation and their use in therapy | |
| AU2001280608A1 (en) | Human polynucleotides and polypeptides encoded thereby | |
| ZA983740B (en) | Novel amidine derivatives and their use in therapy | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| PL338123A1 (en) | 6-pyrrolydin-2-ylpyridines, their production and application in therapy | |
| IL156863A0 (en) | Polynucleotides and polypeptides and their use in metabolic disorders | |
| AU2002246858A1 (en) | Human kinases and polynucleotides encoding the same | |
| AU2002213183A1 (en) | Human kinases and polynucleotides encoding the same | |
| IL156864A0 (en) | Polynucleotides and polypeptides and their use in metabolic disorders | |
| AU3264202A (en) | Novel human kinases and polynucleotides encoding the same | |
| GB0031021D0 (en) | Polynucleotides and polypeptides | |
| GB0017028D0 (en) | Peptides and their therapeutic use | |
| AU2002215312A1 (en) | Human proteases and polynucleotides encoding the same | |
| AU2001272919A1 (en) | Lp120 polypeptides and therapeutic uses thereof | |
| GB0026428D0 (en) | Hydroimidazolone derivatives and their use in therapy | |
| AU4726901A (en) | Novel human proteins and polynucleotides encoding the same | |
| AU2002228633A1 (en) | Human kinases and polynucleotides encoding the same | |
| AU2002314059A1 (en) | Oxazolo-and furopyrimidines and their use in medicaments against tumors | |
| GB0001926D0 (en) | Biaryl compounds their preparation and their use in therapy | |
| HK1060530A (en) | Crf2-ligands in combination therapy |